RS51621B - Novi gama kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto - Google Patents

Novi gama kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto

Info

Publication number
RS51621B
RS51621B YU100302A YUP100302A RS51621B RS 51621 B RS51621 B RS 51621B YU 100302 A YU100302 A YU 100302A YU P100302 A YUP100302 A YU P100302A RS 51621 B RS51621 B RS 51621B
Authority
RS
Serbia
Prior art keywords
crystalline form
perindopril
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
YU100302A
Other languages
English (en)
Inventor
Bruno Pfeiffer
Yves-Michel Ginot
Gérard Coquerel
Stéphane Beilles
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51621(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of YU100302A publication Critical patent/YU100302A/sh
Publication of RS51621B publication Critical patent/RS51621B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

γ kristalni oblik jedinjenja sa formulom (I):koji se karakteriše sfedećim dijagramom praha, koji je meren korišćenjem difraktometra (bakarna antikatoda). i koji je izražen u pogledu inter-planarnog rastojanja d, Bragovog ugla 2 teta, intenziteta i relativnog intenziteta (izraženog kao -procenat od najintezivnijeg rendgentskog zraka).Ugao 2 teta(º) Inter-planarrno rastojanjed (A) Intenzitet Relativni intenzitet(%)6.298 14.02 630 39.87.480 11.81 380 248.700 10.16 1584 1009.276 9.53 318 20.110.564 8.37 526 33.211.801 7.49 54 3.412.699 6.96 86 5.413.661 6.48 178 11,214.095 6.28 163 10.314.332 6.17 290 18.314.961 5.92 161 10.215.793 5.61 128 8.116.212 5.46 179 11.316.945 5.23 80 5,117.291 5.12 92 5.817.825 4.97 420 26.518.100 4.90 159 1018.715 4.74 89 5.619.017 4.66 118 7.419.362 4.58 134 8.519.837 4.47 133 8.420.609 4.31 95 621.232 4.18 257 16.221.499 4.13 229 14.521.840 4.07 127 822.129 4.01 191 12.122.639 3.92 137 8.623.000 3.86 88 5.623.798 3.74 147 9.324.170 3.68 70 4.425.066 3.55 167 10.525.394 3.50 165 10.426.034 3.42 84 5.326.586 3.35 75 4.727.541 3.24 74 4.728.330 3.15 85 5.429.589 3.02 96 6.1Prijava sadrži još 10 patentnih zahteva.
YU100302A 2000-07-06 2001-07-06 Novi gama kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto RS51621B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008791A FR2811318B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002169 WO2001083439A2 (fr) 2000-07-06 2001-07-06 NOUVELLE FORME CRISTALLINE η DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (2)

Publication Number Publication Date
YU100302A YU100302A (sh) 2003-08-29
RS51621B true RS51621B (sr) 2011-08-31

Family

ID=8852170

Family Applications (1)

Application Number Title Priority Date Filing Date
YU100302A RS51621B (sr) 2000-07-06 2001-07-06 Novi gama kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto

Country Status (36)

Country Link
US (2) US20030158121A1 (sr)
EP (1) EP1296948B1 (sr)
JP (2) JP3592296B2 (sr)
KR (1) KR100513572B1 (sr)
CN (1) CN1328258C (sr)
AP (1) AP1452A (sr)
AR (1) AR029570A1 (sr)
AT (1) ATE249435T1 (sr)
AU (2) AU7642001A (sr)
BG (1) BG66239B1 (sr)
BR (1) BR0112211A (sr)
CA (1) CA2415447C (sr)
CZ (1) CZ302022B6 (sr)
DE (1) DE60100761T2 (sr)
DK (1) DK1296948T3 (sr)
EA (1) EA004275B1 (sr)
EE (1) EE05286B1 (sr)
ES (1) ES2206423T3 (sr)
FR (1) FR2811318B1 (sr)
GE (1) GEP20043362B (sr)
HK (1) HK1058199A1 (sr)
HR (1) HRP20030078B1 (sr)
HU (1) HU228115B1 (sr)
ME (1) ME01367B (sr)
MX (1) MXPA02012904A (sr)
NO (1) NO323445B1 (sr)
NZ (1) NZ523311A (sr)
OA (1) OA12306A (sr)
PL (1) PL348491A1 (sr)
PT (1) PT1296948E (sr)
RS (1) RS51621B (sr)
SI (1) SI1296948T1 (sr)
SK (1) SK287452B6 (sr)
UA (1) UA57187C2 (sr)
WO (1) WO2001083439A2 (sr)
ZA (1) ZA200300025B (sr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
ES2382171T3 (es) 2003-06-24 2012-06-06 Les Laboratoires Servier Nuevas formas cristalinas de perindopril erbumina
WO2005019173A1 (en) * 2003-08-21 2005-03-03 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
ATE452124T1 (de) 2003-10-21 2010-01-15 Servier Lab Verfahren zur herstellung kristallinem perindopril erbumin
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
HUE031058T2 (en) * 2004-03-29 2017-06-28 Servier Lab A method of producing a solid pharmaceutical composition
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
AU2006281681A1 (en) * 2005-08-12 2007-02-22 Sandoz Ag New crystalline form of perindopril erbumine
US20100016614A1 (en) * 2005-08-12 2010-01-21 Lek Pharmaceuticals D.D Process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
PL2318365T3 (pl) * 2008-06-24 2016-02-29 Mylan Laboratories Ltd Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania
KR200453510Y1 (ko) * 2009-02-09 2011-05-11 윤유원 튀김유 정제기
KR101041878B1 (ko) * 2009-03-26 2011-06-15 신준호 튀김장치용 찌꺼기 제거장치
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EA004275B1 (ru) 2004-02-26
JP2003531890A (ja) 2003-10-28
JP2005002120A (ja) 2005-01-06
CA2415447A1 (fr) 2001-11-08
NO20030051D0 (no) 2003-01-06
EP1296948B1 (fr) 2003-09-10
DK1296948T3 (da) 2004-01-05
FR2811318B1 (fr) 2002-08-23
GEP20043362B (en) 2004-06-10
OA12306A (en) 2003-12-23
SK1502003A3 (en) 2003-06-03
PL348491A1 (en) 2002-01-14
UA57187C2 (uk) 2003-06-16
CN1328258C (zh) 2007-07-25
NO20030051L (no) 2003-01-06
SI1296948T1 (en) 2003-12-31
PT1296948E (pt) 2003-12-31
US20040248817A1 (en) 2004-12-09
WO2001083439A2 (fr) 2001-11-08
HK1058199A1 (en) 2004-05-07
CZ2003358A3 (cs) 2003-05-14
JP3592296B2 (ja) 2004-11-24
EA200300104A1 (ru) 2003-06-26
MXPA02012904A (es) 2003-09-22
AP2002002709A0 (en) 2002-12-31
AU7642001A (en) 2001-11-12
YU100302A (sh) 2003-08-29
EE05286B1 (et) 2010-04-15
CZ302022B6 (cs) 2010-09-08
NZ523311A (en) 2004-06-25
HUP0102814A2 (hu) 2002-02-28
BG107534A (bg) 2003-12-31
WO2001083439A3 (fr) 2002-02-07
KR20030024774A (ko) 2003-03-26
JP5016184B2 (ja) 2012-09-05
ATE249435T1 (de) 2003-09-15
HUP0102814A3 (en) 2003-12-29
HRP20030078B1 (en) 2004-06-30
FR2811318A1 (fr) 2002-01-11
ME01367B (me) 2013-12-20
CN1440386A (zh) 2003-09-03
NO323445B1 (no) 2007-05-07
CA2415447C (fr) 2008-12-09
KR100513572B1 (ko) 2005-09-09
DE60100761T2 (de) 2004-07-15
EE200300003A (et) 2004-08-16
ES2206423T3 (es) 2004-05-16
HU0102814D0 (en) 2001-09-28
AU2001276420B2 (en) 2006-11-16
HU228115B1 (hu) 2012-11-28
ZA200300025B (en) 2004-02-10
US20030158121A1 (en) 2003-08-21
EP1296948A2 (fr) 2003-04-02
BG66239B1 (bg) 2012-08-31
AR029570A1 (es) 2003-07-02
DE60100761D1 (de) 2003-10-16
HRP20030078A2 (en) 2003-04-30
AP1452A (en) 2005-07-11
SK287452B6 (sk) 2010-10-07
BR0112211A (pt) 2003-05-06

Similar Documents

Publication Publication Date Title
RS51621B (sr) Novi gama kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto
RS50915B (sr) α KRISTALNI OBLIK TERCIJALNE BUTILAMINSKE SOLI PERINDOPRILA
TW200736199A (en) New crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
EA200300103A1 (ru) НОВАЯ β КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
TW200736198A (en) New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
ATE78813T1 (de) Piperidinderivat, seine verwendung und diese enthaltende pharmazeutische zusammensetzung.
NO924394D0 (no) Fremgangsmaate for fremstilling av amidderivater fra halogenaminer og syrehalogenider
DE69713582T2 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
ATE297910T1 (de) Retinoid x rezeptormodulatoren
BG104148A (en) Indole and 2,3-dihydroindole derivatives, their preparation and use
PL374024A1 (en) Terphenyl derivatives, preparation thereof, compositions containing same
HUP0000480A2 (hu) N-(fenil-acetil)-N-(2,6-xilil)-metil-alaninát(benalaxil) alapú fungicid készítmények, alkalmazásuk és eljárás a benalaxil előállítására
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
NO934761D0 (no) Antidepresjons- og antiparkinsonisme-forbindelser
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
TR200200804T2 (tr) Polimorfik tuz
DE69814612D1 (de) Stoffe zur hemmung der bildung des pterygiums und seines postoperative wiederauftretens
ATE365722T1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s- triazin, dieser enthaltenden sonnenschutzzusammensetzungen und dessen verwendungen
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
MEP38508A (en) Benzofuran derivatives, their preparation and use
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
ES8609307A1 (es) 1,4-dihidropiridinas
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it